8 December 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 5th & 8th December 2025 respectively of the following share purchases:
· Paul Higgs, Director and Chief Veterinary Officer of the Company purchased 1,235 Ordinary Shares. As a result Paul Higgs's total interest in the Company is now 4,931 Ordinary shares, representing 0.007 per cent of the total voting rights of the Company.
· Joanne Shaw, Non-Executive Director of the Company purchased 825 Ordinary Shares. As a result Joanne Shaw's total interest in the Company is now 2,387 Ordinary shares, representing 0.003 per cent of the total voting rights of the Company.
The notifications below, made in accordance with the requirements of UK MAR, provide further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial PR)
Ginny Pulbrook +44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Paul Higgs | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| PDMR (Director and Chief Veterinary Officer) | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| CVS Group plc | ||||
| b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.2 pence each
GB00B2863827
| ||||
| b)
| Nature of the transaction
| On-market purchase | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction | ||||
| e)
| Date of the transaction
| 5 December 2025 | ||||
| f)
| Place of the transaction
| London Stock Exchange - AIM (XLON) | ||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Joanne Shaw | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| PDMR (Non-Executive Director) | ||||
| b)
| Initial notification /Amendment
| Initial Notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| CVS Group plc | ||||
| b)
| LEI
| 213800J41XDQ2NX48O05 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 0.2 pence each
GB00B2863827
| ||||
| b)
| Nature of the transaction
| On-market purchase | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction | ||||
| e)
| Date of the transaction
| 5 December 2025 | ||||
| f)
| Place of the transaction
| London Stock Exchange - AIM (XLON) | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
